Notes:
The European Atrial Fibrillation Trial (EAFT) was a randomized comparison of anticoagulation, aspirin and placebo in AF patients who had suffered a recent stroke or TIA. This study provided an opportunity to compare the effectiveness of aspirin with both oral anticoagulants and placebo and to help determine whether the lack of aspirin response in the AFASAK trial was related to the lower dose of aspirin used in that study. Mean duration of follow up was 2.3 years.

Back

Contents

Next

Acknowledgments:
The content of this presentation was prepared by Dr. Gregory Albers of the Stanford Stroke Center.